+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Indole and Oxindoles 934541-31-8
934541-31-8,MFCD18782651
Catalog No.:AA00GU3V

934541-31-8 | 5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$63.00   $44.00
- +
5mg
98%(HPLC)
in stock  
$110.00   $77.00
- +
25mg
98%(HPLC)
in stock  
$266.00   $186.00
- +
100mg
98%(HPLC)
in stock  
$777.00   $544.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00GU3V
Chemical Name:
5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide
CAS Number:
934541-31-8
Molecular Formula:
C28H32N4O3S
Molecular Weight:
504.6437
MDL Number:
MFCD18782651
SMILES:
CCS(=O)(=O)c1cccc(c1)c1cc(C(=O)NC2CCN(CC2)C)c(c2c1c1cc(C)cnc1[nH]2)C
Properties
Computed Properties
 
Complexity:
884  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
4.5  

Downstream Synthesis Route

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2009/270442,2009,A1Locationinpatent:Page/Pagecolumn24-25

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2009/129259,2009,A2Locationinpatent:Page/Pagecolumn48;50-51

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2009/129401,2009,A1Locationinpatent:Page/Pagecolumn298-299

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2007/44779,2007,A1Locationinpatent:Page/Pagecolumn268

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2009/270442,2009,A1Locationinpatent:Page/Pagecolumn24-25

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2009/129259,2009,A2Locationinpatent:Page/Pagecolumn48;50

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2009/129401,2009,A1Locationinpatent:Page/Pagecolumn296;298

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2009/129259,2009,A2Locationinpatent:Page/Pagecolumn51

Literature

Title: Farrell P, et al. Biological characterization of TAK-901, an investigational, novel, multitargeted Aurora B kinase inhibitor. Mol Cancer Ther. 2013 Apr;12(4):460-70.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 934541-31-8
Building Blocks
More >
Tags:934541-31-8 Molecular Formula|934541-31-8 MDL|934541-31-8 SMILES|934541-31-8 5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide